|
Neurology Devices Market Outlook in United States to 2016 - Neurostimulation Devices, Interventional Neurology and Others
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
|||||||||||
| Zahlen und Fakten zur Studie: |
Will be delivered within two days. 194 Pages | |||||||||||
| Inhalt der Studie: |
Introduction
GlobalData’s medical device report, “Neurology Devices Market Outlook in the US to 2016 - Neurostimulation Devices, Interventional Neurology and Others” provides key market data on the U.....
Introduction GlobalData’s medical device report, “Neurology Devices Market Outlook in the US to 2016 - Neurostimulation Devices, Interventional Neurology and Others” provides key market data on the US Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories – CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery. Segments include Hydrocephalus Shunts, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Embolic Systems, Navigational Systems, CyberKnife Radiosurgery and Others.The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Market size and company share data for Neurology Devices market categories – CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery - Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. Segments include Hydrocephalus Shunts, Vagus Nerve Stimulators, Spinal Cord Stimulators, Deep Brain Stimulators, Embolic Systems, Navigational Systems, CyberKnife Radiosurgery and Others. - 2009 company shares and distribution shares data for each of the five market categories. - Global corporate-level profiles of key companies operating within the US Neurology Devices market. - Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cordis Corporation, Cyberonics, Inc. and others. Highlights Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth. - Explore investment opportunites in the market. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the competitive landscape. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. Report Highlights Medtronic, Inc. Boston Scientific Corporation St. Jude Medical, Inc. Cyberonics, Inc. Cordis Corporation Accuray Incorporated Elekta AB ev3 Inc. Micrus Endovascular Corporation Codman & Shurtleff, Inc. Integra LifeSciences Holdings Corporation B. Braun Melsungen AG Terumo Corporation KARL STORZ GmbH & Co. KG [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS 1 Table of Contents 2 1.1 List of Tables 9 1.2 List of Figures 11 2 Introduction 13 2.1 What is This Report About? 13 3 Neurology Devices In United States 14 3.1 Neurology Devices, Market Segmentation 14 3.2 Neurology Devices, United States, Overall Revenue ($m), 2002-2016 15 3.3 Neurology Devices Market, United States, Revenue Mix ($m), 2009 17 3.4 Neurology Devices Market, United States, Category Contribution (%), 2009 18 3.5 Neurology Devices, United States, Category Volume (Units), 2002-2016 24 3.6 Neurology Devices, United States, Company Share (2008-2009) 29 4 CSF Management In United States 31 4.1 CSF Management, Market Segmentation 31 4.2 CSF Management Market, United States, Revenue Mix ($m), 2009 32 4.3 CSF Management Market, United States, Segment Contribution (%), 2009 33 4.4 CSF Management Overall Revenue (2002-2016) 34 4.5 CSF Management Overall Volume (2002-2016) 38 4.6 CSF Management Average Price (2002-2016) 42 4.7 CSF Management Distribution Share (2008-2009) 43 4.8 CSF Management, United States, Company Share (2008-2009) 44 5 Interventional Neurology In United States 46 5.1 Interventional Neurology, Market Segmentation 46 5.2 Interventional Neurology Market, United States, Revenue Mix ($m), 2009 47 5.3 Interventional Neurology Market, United States, Segment Contribution (%), 2009 48 5.4 Interventional Neurology Overall Revenue (2002-2016) 49 5.4.1 Embolic Systems Revenue (2002-2016) 53 5.4.2 Navigational Systems Revenue (2002-2016) 57 5.5 Interventional Neurology Overall Volume (2002-2016) 61 5.5.1 Embolic Systems Volume (2002-2016) 65 5.5.2 Navigational Systems Volume (2002-2016) 69 5.6 Interventional Neurology Average Price (2002-2016) 73 5.7 Interventional Neurology Distribution Share (2008-2009) 74 5.8 Interventional Neurology, United States, Company Share (2008-2009) 75 6 Neurostimulation Devices In United States 77 6.1 Neurostimulation Devices, Market Segmentation 77 6.2 Neurostimulation Devices Market, United States, Revenue Mix ($m), 2009 78 6.3 Neurostimulation Devices Market, United States, Segment Contribution (%), 2009 79 6.4 Neurostimulation Devices Overall Revenue (2002-2016) 80 6.5 Neurostimulation Devices Overall Volume (2002-2016) 84 6.6 Neurostimulation Devices Average Price (2002-2016) 88 6.7 Neurostimulation Devices Distribution Share (2008-2009) 89 6.8 Neurostimulation Devices, United States, Company Share (2008-2009) 90 7 Neurosurgical Products In United States 92 7.1 Neurosurgical Products Overall Revenue (2002-2016) 92 7.2 Neurosurgical Products Overall Volume (2002-2016) 94 7.3 Neurosurgical Products Average Price (2002-2016) 96 7.4 Neurosurgical Products Distribution Share (2008-2009) 97 7.5 Neurosurgical Products, United States, Company Share (2008-2009) 98 8 Radiosurgery In United States 99 8.1 Radiosurgery, Market Segmentation 99 8.2 Radiosurgery Market, United States, Revenue Mix ($m), 2009 100 8.3 Radiosurgery Market, United States, Segment Contribution (%), 2009 101 8.4 Radiosurgery Overall Revenue (2002-2016) 102 8.5 Radiosurgery Overall Volume (2002-2016) 106 8.6 Radiosurgery Average Price (2002-2016) 110 8.7 Radiosurgery Distribution Share (2008-2009) 111 8.8 Radiosurgery, United States, Company Share (2008-2009) 112 9 Overview of Key Companies in United States Neurology Devices Market 113 9.1 Medtronic, Inc. 113 9.1.1 Company Overview 113 9.1.2 Share in the United States Neurology Devices Market 113 9.2 Boston Scientific Corporation 114 9.2.1 Company Overview 114 9.2.2 Share in the United States Neurology Devices Market 115 9.3 St. Jude Medical, Inc. 116 9.3.1 Company Overview 116 9.3.2 Share in the United States Neurology Devices Market 116 9.4 Cyberonics, Inc. 117 9.4.1 Company Overview 117 9.4.2 Share in the United States Neurology Devices Market 117 9.5 Cordis Corporation 118 9.5.1 Company Overview 118 9.5.2 Share in the United States Neurology Devices Market 118 9.6 Accuray Incorporated 119 9.6.1 Company Overview 119 9.6.2 Share in the United States Neurology Devices Market 119 9.7 Elekta AB 120 9.7.1 Company Overview 120 9.7.2 Share in the United States Neurology Devices Market 120 9.8 ev3 Inc. 121 9.8.1 Company Overview 121 9.8.2 Share in the United States Neurology Devices Market 121 9.9 Micrus Endovascular Corporation 122 9.9.1 Company Overview 122 9.9.2 Share in the United States Neurology Devices Market 122 9.10 Codman & Shurtleff, Inc. 123 9.10.1 Company Overview 123 9.11 Integra LifeSciences Holdings Corporation 123 9.11.1 Company Overview 123 9.12 B. Braun Melsungen AG 123 9.12.1 Company Overview 123 9.13 Terumo Corporation 124 9.13.1 Company Overview 124 9.14 KARL STORZ GmbH & Co. KG 124 9.14.1 Company Overview 124 10 Neurology Devices Market Pipeline Products 125 11 Financial Deals Landscape 129 11.1 Acquisition 129 11.1.1 HealthMed Services to Acquire Neural Communicator 129 11.1.2 Masimo Completes Acquisition of SEDLine 130 11.1.3 Johnson & Johnson To Acquire Micrus Endovascular For $480 Million 131 11.1.4 Covidien Completes Acquisition Of ev3 For $2.6 Billion 133 11.1.5 SEDLine Receives Investment Of $3.5 Million From Masimo 135 11.1.6 CareFusion Receives Tender Offer For Acquisition From TRC Capital 136 11.1.7 Sonova Holding Acquires Advanced Bionics 137 11.1.8 SANUWAVE Completes Reverse Acquisition With Rub Music Enterprises 139 11.1.9 Natus Medical Acquires Alpine Biomed 141 12 Recent Developments 143 12.1 Strategy and Business Planning 143 12.1.1 Aug 26, 2010: Pico-Tesla Opens New Facility in Michigan 143 12.1.2 Aug 24, 2010: Cyberonics Signs Epilepsy Technology Agreements With NeuroVista In Field Of EEG-based Seizure Detection 143 12.1.3 Aug 20, 2010: Integra Opens Center For Research, Education And Training In Irvine, California 144 12.1.4 Aug 19, 2010: Boston Scientific To Invest In New Products: CEO 144 12.1.5 Aug 10, 2010: CareFusion Announces Company-Wide Restructuring 144 12.1.6 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany 145 12.1.7 May 06, 2010: Swedish Cancer Institute And Elekta Renew Partnership Agreement 145 12.1.8 Apr 20, 2010: Siemens Opens National Customer Service Headquarters For 24x7 Service And Support 146 12.1.9 Mar 17, 2010: EnteroMedics Extends Collaboration Agreement With Mayo Clinic For Two Years 146 12.1.10 Mar 15, 2010: Pico-Tesla Opens Florida Office 147 12.1.11 Feb 24, 2010: Zynex Announces Development Of Two New Business Units 147 12.1.12 Feb 17, 2010: Greatbatch Medical Opens New Orthopaedic Design Center In Warsaw, Indiana 147 12.1.13 Feb 11, 2010: St. Jude Medical Expands In Austin, Texas 148 12.1.14 Nov 24, 2009: Paragon Innovations To Shift Its Headquarters To Richardson, Texas 148 12.1.15 Oct 21, 2009: Accuray Announces Regionalized Management Strategy For Americas 149 12.2 Legal and Regulatory 150 12.2.1 Aug 10, 2010: Best Medical Files Patent Infringement Lawsuit against Accuray 150 12.2.2 Jul 12, 2010: Law Offices Of Howard G. Smith Investigates Micrus Acquisition For Shareholders 150 12.2.3 Jul 06, 2010: ev3 Agrees To Settle Stockholder Litigation 150 12.2.4 Jun 01, 2010: Finkelstein Thompson LLP Announces Investigation Of ev3 151 12.2.5 Apr 09, 2010: Robbins Geller Files Class Action Suit Against Boston Scientific 151 12.2.6 Mar 18, 2010: Coughlin Stoia Files Class Action Suit Against St. Jude Medical 151 12.2.7 Feb 23, 2010: Astro-Med Wins $1.5 Million Employee Non-Compete Agreement Suit 152 12.2.8 Jan 11, 2010: Holzer Holzer & Fistel Is Investigating Potential Violations Of Federal Securities Laws By St. Jude Medical 152 12.2.9 Dec 14, 2009: NeuroMetrix Reports Dismissal Of Securities Class Action Lawsuit 153 12.2.10 Dec 14, 2009: NeuroMetrix Announces Dismissal Of Securities Class Action Lawsuit 153 12.2.11 Sep 24, 2009: Synergetics Announces Stay Of Alcon Patent And Trademark Infringement Lawsuit 153 12.3 Government and Public Interest 154 12.3.1 Aug 25, 2010: Research Heralds Potential For Early Diagnosis Of Degenerative Brain Disorders 154 12.3.2 Aug 22, 2010: Gene Scan Finds Link Across Array Of Childhood Brain Disorders 154 12.3.3 Aug 11, 2010: Boston Scientific Resolves Corporate Warning Letter 156 12.3.4 Jul 22, 2010: Stanford University School Of Medicine Seeks Patient Enrollment For Alzheimer's Study 156 12.3.5 Jul 12, 2010: MRI Better Than CT Scans At Diagnosing Stroke: New Guideline 156 12.3.6 Jun 30, 2010: New Study Identifies Best Tests For Predicting Alzheimer’s Disease: Study 157 12.3.7 Jun 22, 2010: UCLA Brain Scanning Study Has Implications For Advertising, Public Health Campaigns 158 12.3.8 Jun 03, 2010: Governor Designates Cleveland Health And Technology Corridor An Ohio Hub Of Innovation And Opportunity 159 12.3.9 May 11, 2010: Stereotactic Radiosurgery Is Safe And Effective For Selected Children With Arteriovenous Malformations: Mayo Clinic 160 12.3.10 May 04, 2010: Stereotactic Radiosurgery Successful For Most Patients With Large Acoustic Neuromas: Mayo Clinic 161 12.3.11 May 03, 2010: Imaging Study Discovers Brain Development Differences In Kids With Fragile X Syndrome: Study 162 12.3.12 Apr 30, 2010: Tiny Particles May Help Surgeons By Marking Brain Tumors 163 12.3.13 Apr 19, 2010: Surgeons Use Brain Port Device To Treat Brain Cyst 164 12.3.14 Apr 18, 2010: Scientists Develop Brain-Recording Device To Control Seizures 165 12.3.15 Apr 16, 2010: Clinical Study Shows Patients Gain Limb Movement Years After Stroke 166 12.3.16 Apr 09, 2010: CDRH: Research Needed To Explore Side Effects Of Pediatric Devices 167 12.3.17 Apr 01, 2010: UC Researchers Quantify Benefits Of Minimally Invasive Removal For Tumors 167 12.3.18 Mar 22, 2010: Scans Of Brain Networks May Help Predict Injury's Effects 169 12.3.19 Mar 15, 2010: Study: Mechanomyography To Be Accurate In Detecting Nerves 170 12.3.20 Mar 04, 2010: Brain Scans Could Be Marketing Tool Of The Future 171 12.3.21 Mar 02, 2010: Scientists Redesigns 3-D Hand Movement Using Brain Signals 171 12.3.22 Feb 09, 2010: Neuroimaging Study May Pave Way For Effective Alzheimer’s Treatments 172 12.3.23 Feb 01, 2010: FDA Approves Novel Study Of Neurostimulation As Treatment For Heart Disease 173 12.3.24 Jan 05, 2010: Congress Allocates $1.6 Million To Worcester Polytechnic Institute For Research On Advanced Neuroprosthetics 174 12.3.25 Dec 30, 2009: Guideline: Widely Used Device For Pain Therapy Not Recommended For Chronic Low-Back Pain 175 12.3.26 Dec 23, 2009: APA Urges Reclassification Of Electroconvulsive Therapy By FDA In Order To Maintain Availability 176 12.3.27 Nov 17, 2009: Investigational Neurostimulation Device Aims To Reduce Stroke Damage 176 12.3.28 Nov 17, 2009: DEP Fines Valley Advanced Gamma Knife For Abandoning Radioactive Equipment, Violating Radiation Protection Act 177 12.3.29 Nov 11, 2009: Imaging Study Shows Brain Abnormalities In Chemotherapy Patients 177 12.3.30 Oct 20, 2009: Boston Scientific Warns Against $4 Billion Medical Device Tax 179 12.3.31 Oct 08, 2009: Radiation Costs Vary Widely By Delivery, U-M Study Finds 179 12.3.32 Sep 29, 2009: A Step Toward Better Brain Implants Using Conducting Polymer Nanotubes 180 12.4 Product News 181 12.4.1 Aug 10, 2010: NKI To Present Two Research Studies On I-Portal NOTC System At Barany Society Conference 181 12.4.2 Jul 15, 2010: Elekta To Highlight Intelligent Cancer Management Solutions At 2010 AAPM Annual Meeting 181 12.4.3 May 05, 2010: Terumo Announces Its Program For The Global Embolization Symposium And Technologies (GEST) Meeting 182 12.4.4 Mar 09, 2010: MIT Selects Elekta Neuromag To Explore Brain Function 182 12.4.5 Mar 01, 2010: Integra Launches OSV II Lumbar And OSV II Low Flow Lumbar Self-Adjusting Valves 184 12.4.6 Feb 23, 2010: Barnes-Jewish Hospital Treats More Patients With Elekta’s Extend Program For Gamma Knife Perfexion 184 12.4.7 Dec 23, 2009: Neuronetics To Complete Johns Hopkins University Phase II Study For NeuroStar TMS Therapy System In Second Half Of 2011 185 12.4.8 Dec 21, 2009: CyberKnife Institute To Treat Its Inoperable Tumors Patients With CyberKnife Robotic Radiosurgery System 186 13 Appendix 187 13.1 Definitions of Markets Covered in the Report 188 13.1.1 Neurology Devices 188 13.2 Research Methodology 191 13.3 Secondary Research 191 13.4 Primary Research 192 13.5 Models 192 13.6 Forecasts 193 13.7 Expert Panels 193 13.8 GlobalData Consulting 193 13.9 Contact Us 194 13.10 Disclaimer 194 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
LIST OF TABLES 1.1 List of Tables Table 1: Neurology Devices, United States, Overall Revenue ($m), 2002-2016 16 Table 2: Neurology Devices Market, United States, Category Contribution (%), 2009 18 Table 3: Neurology Devices, United States, Cross-Category Analysis, 2002-2016 19 Table 4: Neurology Devices, United States, Overall Revenue ($m), Historic, 2002-2009 21 Table 5: Neurology Devices, United States, Overall Revenue ($m), Forecast, 2009-2016 23 Table 6: Neurology Devices, United States, Category Volume (Units), 2002-2016 24 Table 7: Neurology Devices, United States, Category Volume (Units), Historic, 2002-2009 26 Table 8: Neurology Devices, United States, Category Volume (Units), Forecast, 2009-2016 28 Table 9: Neurology Devices, United States, Company Share by Revenue ($m), 2008-2009 30 Table 10: CSF Management Market, United States, Segment Contribution (%), 2009 33 Table 11: CSF Management, United States, Revenue ($m) by Segment, Historic, 2002-2009 35 Table 12: CSF Management, United States, Revenue ($m) by Segment, Forecast, 2009-2016 37 Table 13: CSF Management, United States, Volume (Units) by Segment, Historic, 2002-2009 39 Table 14: CSF Management, United States, Volume (Units) by Segment, Forecast, 2009-2016 41 Table 15: CSF Management, United States, Average Price ($), Historic, 2002-2009 42 Table 16: CSF Management, United States, Average Price ($), Forecast, 2009-2016 42 Table 17: CSF Management, United States, Distribution Share by Revenue ($m), 2008-2009 43 Table 18: CSF Management, United States, Company Share by Revenue ($m), 2008-2009 45 Table 19: Interventional Neurology Market, United States, Segment Contribution (%), 2009 48 Table 20: Interventional Neurology, United States, Revenue ($m) by Segment, Historic, 2002-2009 50 Table 21: Interventional Neurology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 52 Table 22: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 54 Table 23: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 56 Table 24: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 58 Table 25: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 60 Table 26: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2002-2009 62 Table 27: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2009-2016 64 Table 28: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 66 Table 29: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 68 Table 30: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 70 Table 31: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 72 Table 32: Interventional Neurology, United States, Average Price ($), Historic, 2002-2009 73 Table 33: Interventional Neurology, United States, Average Price ($), Forecast, 2009-2016 73 Table 34: Interventional Neurology, United States, Distribution Share by Revenue ($m), 2008-2009 74 Table 35: Interventional Neurology, United States, Company Share by Revenue ($m), 2008-2009 76 Table 36: Neurostimulation Devices Market, United States, Segment Contribution (%), 2009 79 Table 37: Neurostimulation Devices, United States, Revenue ($m) by Segment, Historic, 2002-2009 81 Table 38: Neurostimulation Devices, United States, Revenue ($m) by Segment, Forecast, 2009-2016 83 Table 39: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2002-2009 85 Table 40: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2009-2016 87 Table 41: Neurostimulation Devices, United States, Average Price ($), Historic, 2002-2009 88 Table 42: Neurostimulation Devices, United States, Average Price ($), Forecast, 2009-2016 88 Table 43: Neurostimulation Devices, United States, Distribution Share by Revenue ($m), 2008-2009 89 Table 44: Neurostimulation Devices, United States, Company Share by Revenue ($m), 2008-2009 91 Table 45: Neurosurgical Products, United States, Revenue ($m), Historic, 2002-2009 92 Table 46: Neurosurgical Products, United States, Revenue ($m), Forecast, 2009-2016 93 Table 47: Neurosurgical Products, United States, Volume (Units), Historic, 2002-2009 94 Table 48: Neurosurgical Products, United States, Volume (Units), Forecast, 2009-2016 95 Table 49: Neurosurgical Products, United States, Average Price ($), Historic, 2002-2009 96 Table 50: Neurosurgical Products, United States, Average Price ($), Forecast, 2009-2016 96 Table 51: Neurosurgical Products, United States, Distribution Share by Revenue ($m), 2008-2009 97 Table 52: Neurosurgical Products, United States, Company Share by Revenue ($m), 2008-2009 98 Table 53: Radiosurgery Market, United States, Segment Contribution (%), 2009 101 Table 54: Radiosurgery, United States, Revenue ($m) by Segment, Historic, 2002-2009 103 Table 55: Radiosurgery, United States, Revenue ($m) by Segment, Forecast, 2009-2016 105 Table 56: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2002-2009 107 Table 57: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2009-2016 109 Table 58: Radiosurgery, United States, Average Price ($), Historic, 2002-2009 110 Table 59: Radiosurgery, United States, Average Price ($), Forecast, 2009-2016 110 Table 60: Radiosurgery, United States, Distribution Share by Revenue ($m), 2008-2009 111 Table 61: Radiosurgery, United States, Company Share by Revenue ($m), 2008-2009 112 Table 62: Neurology Devices Market Pipeline Products 125 Table 63: HealthMed Services To Acquire Neural Communicator 129 Table 64: Masimo Completes Acquisition Of SEDLine 130 Table 65: Johnson & Johnson To Acquire Micrus Endovascular For $480 Million 131 Table 66: Covidien Completes Acquisition Of ev3 For $2.6 Billion 133 Table 67: SEDLine Receives Investment Of $3.5 Million From Masimo 135 Table 68: CareFusion Receives Tender Offer For Acquisition From TRC Capital 136 Table 69: Sonova Holding Acquires Advanced Bionics 137 Table 70: SANUWAVE Completes Reverse Acquisition With Rub Music Enterprises 139 Table 71: Natus Medical Acquires Alpine Biomed 141 LIST OF FIGURES 1.2 List of Figures Figure 1: Neurology Devices, Market Segmentation 14 Figure 2: Neurology Devices, United States, Overall Revenue ($m), 2002-2016 15 Figure 3: Neurology Devices Market, United States, Revenue Mix ($m), 2009 17 Figure 4: Neurology Devices Market, United States, Category Contribution (%), 2009 18 Figure 5: Neurology Devices, United States, Cross-Category Analysis, 2002-2016 19 Figure 6: Neurology Devices, United States, Overall Revenue ($m), Historic, 2002-2009 20 Figure 7: Neurology Devices, United States, Overall Revenue ($m), Forecast, 2009-2016 22 Figure 8: Neurology Devices, United States, Category Volume (Units), 2002-2016 24 Figure 9: Neurology Devices, United States, Category Volume (Units), Historic, 2002-2009 25 Figure 10: Neurology Devices, United States, Category Volume (Units), Forecast, 2009-2016 27 Figure 11: Neurology Devices, United States, Company Share (%), 2009 29 Figure 12: CSF Management, Market Segmentation 31 Figure 13: CSF Management Market, United States, Revenue Mix ($m), 2009 32 Figure 14: CSF Management Market, United States, Segment Contribution (%), 2009 33 Figure 15: CSF Management, United States, Revenue ($m) by Segment, Historic, 2002-2009 34 Figure 16: CSF Management, United States, Revenue ($m) by Segment, Forecast, 2009-2016 36 Figure 17: CSF Management, United States, Volume (Units) by Segment, Historic, 2002-2009 38 Figure 18: CSF Management, United States, Volume (Units) by Segment, Forecast, 2009-2016 40 Figure 19: CSF Management, United States, Company Share (%), 2009 44 Figure 20: Interventional Neurology, Market Segmentation 46 Figure 21: Interventional Neurology Market, United States, Revenue Mix ($m), 2009 47 Figure 22: Interventional Neurology Market, United States, Segment Contribution (%), 2009 48 Figure 23: Interventional Neurology, United States, Revenue ($m) by Segment, Historic, 2002-2009 49 Figure 24: Interventional Neurology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 51 Figure 25: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 53 Figure 26: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 55 Figure 27: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 57 Figure 28: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 59 Figure 29: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2002-2009 61 Figure 30: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2009-2016 63 Figure 31: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 65 Figure 32: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 67 Figure 33: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 69 Figure 34: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 71 Figure 35: Interventional Neurology, United States, Company Share (%), 2009 75 Figure 36: Neurostimulation Devices, Market Segmentation 77 Figure 37: Neurostimulation Devices Market, United States, Revenue Mix ($m), 2009 78 Figure 38: Neurostimulation Devices Market, United States, Segment Contribution (%), 2009 79 Figure 39: Neurostimulation Devices, United States, Revenue ($m) by Segment, Historic, 2002-2009 80 Figure 40: Neurostimulation Devices, United States, Revenue ($m) by Segment, Forecast, 2009-2016 82 Figure 41: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2002-2009 84 Figure 42: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2009-2016 86 Figure 43: Neurostimulation Devices, United States, Company Share (%), 2009 90 Figure 44: Neurosurgical Products, United States, Revenue ($m), Historic, 2002-2009 92 Figure 45: Neurosurgical Products, United States, Revenue ($m), Forecast, 2009-2016 93 Figure 46: Neurosurgical Products, United States, Volume (Units), Historic, 2002-2009 94 Figure 47: Neurosurgical Products, United States, Volume (Units), Forecast, 2009-2016 95 Figure 48: Neurosurgical Products, United States, Company Share (%), 2009 98 Figure 49: Radiosurgery, Market Segmentation 99 Figure 50: Radiosurgery Market, United States, Revenue Mix ($m), 2009 100 Figure 51: Radiosurgery Market, United States, Segment Contribution (%), 2009 101 Figure 52: Radiosurgery, United States, Revenue ($m) by Segment, Historic, 2002-2009 102 Figure 53: Radiosurgery, United States, Revenue ($m) by Segment, Forecast, 2009-2016 104 Figure 54: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2002-2009 106 Figure 55: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2009-2016 108 Figure 56: Radiosurgery, United States, Company Share (%), 2009 112 Figure 57: Medtronic, Inc., Company Share (%),United States Neurology Devices Market, 2009 113 Figure 58: Boston Scientific Corporation, Company Share (%),United States Neurology Devices Market, 2009 115 Figure 59: St. Jude Medical, Inc., Company Share (%),United States Neurology Devices Market, 2009 116 Figure 60: Cyberonics, Inc., Company Share (%),United States Neurology Devices Market, 2009 117 Figure 61: Cordis Corporation, Company Share (%),United States Neurology Devices Market, 2009 118 Figure 62: Accuray Incorporated, Company Share (%),United States Neurology Devices Market, 2009 119 Figure 63: Elekta AB, Company Share (%),United States Neurology Devices Market, 2009 120 Figure 64: ev3 Inc., Company Share (%),United States Neurology Devices Market, 2009 121 Figure 65: Micrus Endovascular Corporation, Company Share (%),United States Neurology Devices Market, 2009 122 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
